^
BIOMARKER:

Low EMT signature scores

News
Twitter
Trials
Low EMT signature scores
NSCLC
nivolumab
Sensitive: C3 – Early Trials
Low EMT signature scores
NSCLC
pembrolizumab
Sensitive: C3 – Early Trials